VentureMed Group, Inc., a medical device company focused on arteriovenous access and peripheral arterial disease, recently ...

Perfuze, an Ireland-based developer of catheter-based aspiration technology for the treatment of acute ischemic stroke, ...

Embolization has made remarkable advances in recent years, becoming a widely adopted treatment option. The FDA approved the first vascular plug for peripheral vascular embolization in 2004, providing ...

Trestle Biotherapeutics, Inc. recently announced a research collaboration with Humacyte, Inc. Trestle Bio is a ...

Instylla, Inc. announced that it recently submitted the final module of its premarket approval (PMA) application to the FDA ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm-diameter balloon; guidewire-free) Aortic Temporary occlusion of large blood vessels and/or ...

Cerenovus PulseRider Aneurysm Neck Bridging Device T shape, Y shape 2.7–3.5, 3.4–4.5 8.6, 10.6 ...

Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm diameter-balloon; guidewire-free) Distal Intended for temporary occlusion of large vessels ...

Life Seal Vascular Inc, announced the appointment of Matt Thompson, MD, as Chief Executive Officer (CEO). The appointment ...